Double Medical Technology Inc.

SZSE:002901.SZ

33.24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 530.076422.561402.753375.795358.268391.375199.245406.836396.946431.072689.445458.306471.552375.03477.001437.064442.491230.304387.107326.762325.948217.501227.078193.119197.256155.017152.317165.618147.377128.703118.789129.036
Cost of Revenue 192.269136.139133.123140.961108.729118.57588.54187.84673.38984.145123.09866.9270.58250.45766.37961.23666.72229.89456.28641.19153.56529.8855.6433.6535.62826.51423.38629.29124.61723.30823.89921.419
Gross Profit 337.807286.422269.63234.833249.539272.799110.704318.991323.558346.927566.348391.386400.97324.574410.622375.827375.769200.411330.821285.571272.383187.621171.438159.468161.628128.503128.931136.327122.76105.39594.89107.617
Gross Profit Ratio 0.6370.6780.6690.6250.6970.6970.5560.7840.8150.8050.8210.8540.850.8650.8610.860.8490.870.8550.8740.8360.8630.7550.8260.8190.8290.8460.8230.8330.8190.7990.834
Reseach & Development Expenses 72.63259.95190.02866.2562.51763.03370.70583.72855.03847.24658.00842.43435.52631.09843.27729.30430.80324.63932.79625.16424.19418.22419.94514.51316.6913.66313.99213.34527.21039.9590
General & Administrative Expenses -16.7827.562-54.70476.528-16.06125.772-54.95282.04-16.17528.018-38.63251.503-6.616.918-27.30515.057-4.32112.034-19.35412.256-3.2049.803-16.30510.283-18.72525.262-55.28921.896-16.05519.723-41.79220.203
Selling & Marketing Expenses 160.979140.936155.894137.596143.221128.254135.47192.146180.122155.157215.279163.246149.537127.117146.791136.522132.30286.876150.951102.693101.16655.03946.52923.02230.63120.76725.37718.00816.10812.70818.80512.083
SG&A 183.779165.531194.326214.124127.16154.02680.518274.185163.948183.175176.647214.748142.938144.036119.486151.579127.98198.91131.597114.94997.96264.84230.22433.30511.90646.029-29.91139.9040.05332.431-22.98732.286
Other Expenses -12.945-4.977-45.506-4.595-0.668-8.6376.877-75.10828.676-4.772-18.683-0.39-0.4310.009-4.596-0.222-0.3060.017-1.0750.014-0.523-0.440.125-0.2030.259-0.264-1.66-0.1143.3041.6473.8323.654
Operating Expenses 269.357230.459329.86217.122222.14208.429228.099282.805247.662225.648277.727228.147184.616174.788202.477179.4169.851102.174178.709131.014131.61683.19164.31444.11454.6545.06226.98339.12943.34434.50442.44634.107
Operating Income 68.45155.964-60.2327.16942.44565.972-119.42449.8888.775128.221278.62168.753217.866156.769207.533195.861205.308106.039149.333171.405145.628104.634108.669126.582121.32984.206101.8895.27581.44568.34454.58372.276
Operating Income Ratio 0.1290.132-0.150.0720.1180.169-0.5990.1230.2240.2970.4040.3680.4620.4180.4350.4480.4640.460.3860.5250.4470.4810.4790.6550.6150.5430.6690.5750.5530.5310.4590.56
Total Other Income Expenses Net 18.60920.03329.682-4.595-0.668-0.034-0.0310.262-0.216-0.008-18.6835.1231.0816.992-5.209-0.788-0.9157.819-3.85416.8634.338-0.2361.6711.02414.610.502-1.273-2.0685.121-0.9015.9412.419
Income Before Tax 87.05975.996-30.54822.57441.77765.938-119.45550.14288.559128.213259.937168.362217.435156.778202.936195.639205.003106.055148.258171.42145.105104.194108.794126.378121.58883.942100.67695.1384.53869.9958.38475.929
Income Before Tax Ratio 0.1640.18-0.0760.060.1170.168-0.60.1230.2230.2970.3770.3670.4610.4180.4250.4480.4630.4610.3830.5250.4450.4790.4790.6540.6160.5420.6610.5740.5740.5440.4910.588
Income Tax Expense 3.4538.7950.5866.8092.8183.192-3.27613.24414.52213.73940.02124.5424.48821.96322.93528.42326.95816.56323.06132.24716.68518.27819.77815.7613.12513.95414.71114.0968.52712.4047.46514.329
Net Income 76.51561.729-38.7444.18135.32658.209-116.17832.48468.367111.527219.829136.318186.592130.569178.089163.11175.29589.191122.888134.969124.93482.788.119108.051106.69668.58785.10778.77375.21156.46550.63560.517
Net Income Ratio 0.1440.146-0.0960.0110.0990.149-0.5830.080.1720.2590.3190.2970.3960.3480.3730.3730.3960.3870.3170.4130.3830.380.3880.560.5410.4420.5590.4760.510.4390.4260.469
EPS 0.180.15-0.0940.010.0850.14-0.280.0790.170.270.530.340.470.330.440.410.430.220.30.340.320.210.220.270.260.170.220.20.210.160.140.17
EPS Diluted 0.180.15-0.0940.010.0850.14-0.280.0790.170.270.530.340.470.330.440.410.430.220.30.340.320.210.220.270.260.170.220.20.210.160.140.17
EBITDA 122.51382.114-8.6718.68738.32575.532-106.72750.35887.095129.777274.647171.623228.008152.782209.471197.35221.22599.906158.312152.205150.551110.619144.535111.437121.28585.953103.36798.56876.8474.57853.72675.474
EBITDA Ratio 0.2310.194-0.0220.050.1070.193-0.5360.1240.2190.3010.3980.3740.4840.4070.4390.4520.50.4340.4090.4660.4620.5090.6360.5770.6150.5540.6790.5950.5210.5790.4520.585